Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Pirarubicin

Pirarubicin

pharmaceutical raw materials
Pirarubicin structure

Pirarubicin 

structure
  • CAS No:

    72496-41-4

  • Formula:

    C32H37NO12

  • Chemical Name:

    Pirarubicin

  • Synonyms:

    5,12-Naphthacenedione,10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-;5,12-Naphthacenedione,10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,[8S-[8α,10α(S*)]]-;5,12-Naphthacenedione,10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,(8S,10S)-;(8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;4′-O-Tetrahydropyranyladriamycin;THP-Adriamycin;(2′′R)-4′-O-Tetrahydropyranyladriamycin;Pirarubicin;Pinorubicin;(2′′R)-4′-O-Tetrahydropyranyldoxorubicin;Therarubicin;70259-49-3

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

Pirarubicin is an anthracycline antibiotics, acts as a topoisomerase II inhibitor, and is a widely used for treatment of various cancers, in particular, solid tumors.

Pirarubicin Basic Attributes

627.64

627.64

DTXSID2046755

L - Antineoplastic and immunomodulating agents

Characteristics

204.30000

3.85

Red crystalline powder

1.5±0.1 g/cm3

184-186 °C (decomp)

834.7±65.0 °C at 760 mmHg

458.6±34.3 °C

1.671

ethanol: soluble 25mg/mL

2-8°C

LD50 i.v. in mice: 27.8 mg/kg (Umezawa, 1979)

D25 +175 ±25° (c = 0.2 in CHCl3)

Safety Information

NONH for all modes of transport

3

36/37/38

26-37/39

QI9296000

Xi

Drug Information

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

4'-O-tetrahydropyranyladriamycin

Pirarubicin Use and Manufacturing

Methods of Manufacturing

With doxorubicin (Adriarnycin) hydrochloride as raw material. 130 mg of doxorubicin hydrochloride was dissolved in 10 ml of dry N, N-dimethylformamide and reacted with 2 ml of 3, 4-dihydro-2H-pyran at room temperature for 47 hours under the action of catalyst p-toluenesulfonic acid. Separated with a thin layer of prepared silica gel to obtain 14, 4'-bis(O-tetrahydropyranyl) doxorubicin. Then, it was reacted with 0.005mol/L p-toluenesulfonic acid in methanol for 1h at room temperature, and 14-O-tetrahydropyranyl group was removed to obtain pirarubicin.

Uses

Structural analog of Doxorubicin. Antineoplastic

Computed Properties

Molecular Weight:627.6
XLogP3:2.7
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:13
Rotatable Bond Count:7
Exact Mass:627.23157562
Monoisotopic Mass:627.23157562
Topological Polar Surface Area:204
Heavy Atom Count:45
Complexity:1120
Undefined Atom Stereocenter Count:7
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

No specific description provided

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Zhejiang Hisun Pharmaceutical Co., Ltd.

    China China
    Active
  • ShenZhen Main Luck Pharmaceuticals Inc

    China China
    Active
  • Guangzhou Greensyn Pharma Co., Ltd.

    China China
    Inactive

Recommended Suppliers of Pirarubicin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.